HSPA1B and non-small cell lung carcinoma: In contrast, treatment of NSCLC cells for 24 h with increasing doses of BTZ (32–128 nM) highly induced the level of HSPA1 and substantially decreased the level of HSPA2, without affecting the expression of HSPA5 and HSPA8 (Fig. 1E).